Capricor Therapeutics Ratios (2011-2025) | CAPR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
EBT Margin (Quarter)	-12,622.31%	-2,482.54%				-3,830.37%	-400.30%	-800.77%	-260.10%	-188.04%	-103.22%	-6.86%	-97.94%	-276.97%	-555.20%	-62.98%	-194,260.36%
EBIT Margin (Quarter)	-12,644.77%	-2,490.75%				-3,841.79%	-407.00%	-840.33%	-274.04%	-197.76%	-110.97%	-10.60%	-102.66%	-291.86%	-575.24%	-69.15%	-200,103.71%
EBITDA Margin (Quarter)	-12,740.10%	-2,303.00%				-3,725.43%	-395.84%	-802.16%	-260.44%	-185.88%	-105.08%	-5.65%	-97.22%	-282.01%	-557.80%	-55.49%	-189,079.87%
Operating Margin (Quarter)	-12,644.77%	-2,490.75%				-3,841.79%	-407.00%	-840.33%	-274.04%	-197.76%	-110.97%	-10.60%	-102.66%	-291.86%	-575.24%	-69.15%	-200,103.71%
Net Margin (Quarter)	-12,622.31%	-2,482.54%				-3,830.37%	-400.30%	-800.77%	-260.10%	-188.04%	-103.22%	-6.86%	-97.94%	-276.97%	-555.20%	-62.98%	-194,260.36%
FCF Margin (Quarter)	-8,247.46%	-2,370.08%				-3,527.74%	-392.27%	-791.34%	129.32%	-243.87%	-146.53%	-100.53%	-18.77%	-310.94%	-515.18%	-137.33%	-58,706.66%
Efficiency
Assets Average (Quarter)	39.08M	41.74M	41.52M	42.22M	53.13M	61.49M	56.00M	52.01M	51.98M	49.94M	41.58M	47.94M	54.09M	43.86M	65.61M	131.72M	162.12M	143.67M	130.00M	241.19M
Equity Average (Quarter)	32.29M	34.88M	35.06M	34.05M	28.01M	21.69M	17.08M	13.61M	9.00M	4.47M	0.47M	10.41M	20.52M	14.97M	39.88M	106.86M	136.55M	116.31M	94.42M	194.83M
Invested Capital (Quarter)	36.38M	33.38M	36.74M	31.97M	25.22M	18.82M	15.51M	11.88M	6.22M	2.75M	-1.79M	22.60M	18.43M	11.50M	68.26M	145.46M	127.65M	104.98M	83.87M	305.79M
Asset Utilization Ratio (Quarter)	0.00	0.01	0.01	0.01	0.00	0.00	0.03	0.05	0.11	0.19	0.34	0.53	0.60	0.74	0.43	0.21	0.11	0.09	0.09	0.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)	0.00	0.10	0.09	0.13	0.16	0.19	0.22	0.29	0.55	1.24	-1.89	0.15	0.18	0.29	0.05
Debt Ratio (Quarter)	0.00	0.08	0.08	0.10	0.06	0.06	0.06	0.07	0.06	0.07	0.09	0.06	0.07	0.09	0.04
Equity Ratio (Quarter)	0.84	0.84	0.85	0.76	0.38	0.32	0.29	0.24	0.12	0.06	-0.05	0.38	0.37	0.30	0.73	0.85	0.83	0.79	0.66	0.86
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-41.90M	-38.08M	-40.80M	-34.89M	-58.30M	-51.42M	-46.61M	-41.42M	-45.17M	-37.79M	-28.52M	-39.49M	-39.92M	-29.46M	-85.03M	-151.52M	-144.78M	-122.80M	-98.57M	-318.13M
Return Ratios
Return on Sales (Quarter)	-126.22%	-24.83%	-61.76%	-85.26%	-115.38%	-38.30%	-4.00%	-8.01%	-2.60%	-1.88%	-1.03%	-0.07%	-0.98%	-2.77%	-5.55%	-0.63%	-1,942.60%	-5.20%	-7.34%	-8,160.55%
Return on Capital Employed (Quarter)	-0.47%	-0.48%	-0.49%	-0.55%	-0.61%	-0.62%	-0.85%	-1.04%	-2.02%	-2.06%	-3.57%	-1.44%	-0.94%	-1.40%	-0.80%	-0.38%	-0.41%	-0.64%	-0.85%	-0.53%
Return on Assets (Quarter)	-0.43%	-0.44%	-0.45%	-0.49%	-0.44%	-0.42%	-0.50%	-0.56%	-0.56%	-0.58%	-0.70%	-0.47%	-0.45%	-0.64%	-0.52%	-0.31%	-0.34%	-0.49%	-0.63%	-0.42%
Return on Equity (Quarter)	-0.52%	-0.52%	-0.53%	-0.61%	-0.84%	-1.19%	-1.63%	-2.14%	-3.24%	-6.53%	-61.91%	-2.15%	-1.19%	-1.87%	-0.86%	-0.38%	-0.40%	-0.60%	-0.87%	-0.52%

Research Tools

Capricor Therapeutics Ratios (2011-2025) | CAPR

Create an account

Sign In

Reset Password